https://www.live-feeds.com/feed/hype-for-moderna-s-cancer-vaccine-is-running-ahead-of-the-mathContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/hype-for-moderna-s-cancer-vaccine-is-running-ahead-of-the-mathhttps://www.live-feeds.com/feed/hype-for-moderna-s-cancer-vaccine-is-running-ahead-of-the-math#u47242Mon, 24 Aug 2026 06:59:09 +0000Moderna and Merck developed an mRNA vaccine that prevents melanoma from returning, according to trial results. The success of this large-scale trial triggered a surge in Moderna shares and sparked discussions about a potential wave of cancer vaccines. While some observers view the breakthrough as a scientific miracle, others argue that the public hype surrounding the vaccine is currently outstripping the mathematical reality of its impact. The treatment represents a personalized approach to cancer vaccination that could change how physicians treat skin cancer.Why it mattersMelanoma is a highly